UPDATE: Morgan Stanley Reiterates on Walgreen Company on 2QFY14 Earnings Preview

In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company WAG, but removed the $68.00 price target. In the report, Morgan Stanley noted, “WAG shares up 17% since January and holding on to gains March to-date, heading into what is likely to be soft earnings as investors focus on LT opportunities. Key to share performance will be mgmt commentary regarding synergies, timing of step 2 of AB deal, and strategic direction.” Walgreen Company closed on Tuesday at $67.20.